Kirigin Biloš, L. S., Altabas, V., Vukić Dugac, A. & Baretić, M. (2024). The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis. Medicina, 60. (3). doi: 10.3390/medicina60030477
Kirigin Biloš, Lora Stanka, et al. "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis." Medicina, vol. 60, no. 3, 2024. https://doi.org/10.3390/medicina60030477
Kirigin Biloš, Lora Stanka, Velimir Altabas, Andrea Vukić Dugac and Maja Baretić. "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis." Medicina 60, no. 3 (2024). https://doi.org/10.3390/medicina60030477
Kirigin Biloš, L. S., et al. (2024) 'The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis', Medicina, 60(3). doi: 10.3390/medicina60030477
Kirigin Biloš LS, Altabas V, Vukić Dugac A, Baretić M. The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis. Medicina [Internet]. 2024 March 14 [cited 2024 October 04];60(3). doi: 10.3390/medicina60030477
L. S. Kirigin Biloš, V. Altabas, A. Vukić Dugac and M. Baretić, "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis", Medicina, vol. 60, no. 3, March 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:761419. [Accessed: 04 October 2024]